-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Scopus BioPharma Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q2 2023.
- Scopus BioPharma Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $78.1K, a 17.8% decline year-over-year.
- Scopus BioPharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $318K, a 35% decline year-over-year.
- Scopus BioPharma Inc. annual Share-based Payment Arrangement, Expense for 2022 was $352K, a 47.5% decline from 2021.
- Scopus BioPharma Inc. annual Share-based Payment Arrangement, Expense for 2021 was $670K, a 148% increase from 2020.
- Scopus BioPharma Inc. annual Share-based Payment Arrangement, Expense for 2020 was $270K, a 117% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)